Cyclopentyl (2S,4E)-2-amino-5-3-[4-carbamoyl-5 (carbamoylamino)-2-thienyl]phenyl}pent-4-enoate; Cyclopentyl 5-3-[4-carbamoyl-5-(carbamoylamino)-2-thienyl]phenyl}-L-norvalinate; Cyclopentyl (2S,4E)-2-amino-5-3-[4-carbamoyl-5-(carbamoylamino)-2-thienyl]-5-methylphenyl}pent-4-enoate; Cyclopentyl (2S,4E)-2-amino-5-5-[4-carbamoyl-5-(carbamoylamino)-2-thienyl]-2-methylphenyl}pent-4-enoate; Cyclopentyl O-3-[4-carbamoyl-5-(carbamoylamino)-2-thienyl]phenyl}-L-homoserinate; Cyclopentyl O-3-[4-carbamoyl-5-(carbamoylamino)-2-thienylJphenyl}-L-homoserinate; Cyclopentyl N-3-[4-carbamoyl-5-(carbamoylamino)-2-thienyl]benzyl}-L-alaninate; and tert-Butyl N-3-[4-carbamoyl-5-(carbamoylamino)-2-thienyl]benzyl}-L-alaninate are hydrolysed to the corresponding carboxylic acids by intracellular carboxylesterases, and are useful for the inhibition of IKKβ activity.
环戊基(2S,4E)-2-
氨基-5-3-[4-羰胺基-5-(羰胺基
氨基)-2-
噻吩基]苯基}戊-4-烯酸酯;环戊基5-3-[4-羰胺基-5-(羰胺基
氨基)-2-
噻吩基]苯基}-L-
异戊酸酯;环戊基(2S,4E)-2-
氨基-5-3-[4-羰胺基-5-(羰胺基
氨基)-2-
噻吩基]-5-甲基苯基}戊-4-烯酸酯;环戊基(2S,4E)-2-
氨基-5-5-[4-羰胺基-5-(羰胺基
氨基)-2-
噻吩基]-2-甲基苯基}戊-4-烯酸酯;环戊基O-3-[4-羰胺基-5-(羰胺基
氨基)-2-
噻吩基]苯基}-
L-赖氨酸酯;环戊基O-3-[4-羰胺基-5-(羰胺基
氨基)-2-
噻吩基]苯基}-
L-赖氨酸酯;环戊基N-3-[4-羰胺基-5-(羰胺基
氨基)-2-
噻吩基]苯基}-
L-丙氨酸酯;和叔丁基N-3-[4-羰胺基-5-(羰胺基
氨基)-2-
噻吩基]苯基}-
L-丙氨酸酯通过细胞内羧
酯酶水解为相应的
羧酸,并可用于抑制IKKβ活性。